Comment
doi: 10.1016/j.annonc.2023.03.003.
Epub 2023 Mar 23.
Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to 'Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up')
Affiliations
- PMID: 36965575
- DOI: 10.1016/j.annonc.2023.03.003
Item in Clipboard
Comment
Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to 'Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up')
Ann Oncol.
2023 Jun.
Free article
No abstract available
Conflict of interest statement
Disclosure The authors have declared no conflicts of interest.
Comment in
-
Reply to the Letter to the Editor 'Neoadjuvant radiochemotherapy and perioperative chemotherapy does not represent a standard at same priority level for oesophageal adenocarcinomas (in regard to "Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up")' by Cellini et al.Ann Oncol. 2023 Jun;34(6):554-555. doi: 10.1016/j.annonc.2023.03.004. Epub 2023 May 5. Ann Oncol. 2023. PMID: 37295906 No abstract available.
Comment on
-
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.Ann Oncol. 2022 Oct;33(10):992-1004. doi: 10.1016/j.annonc.2022.07.003. Epub 2022 Jul 29. Ann Oncol. 2022. PMID: 35914638 No abstract available.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
